Allen & Overy advising Sensyne Health on GBP225 million AIM IPO
LONDON – A&O is advising healthcare technology company Sensyne Health Plc (Sensyne Health) on its initial public offering (IPO) to raise primary proceeds of GBP60m and admission to trading on AIM, the market operated by the London Stock Exchange, with a market capitalisation of GBP225 million. The IPO priced on 13 August 2018 and admission will take place on 17 August 2018.